Varian, Inc. and Sageful Corporation Announce Strategic Partnership and SMARTesting(TM) Solutions
Varian, Inc. announced a strategic partnership with Sageful Corporation for developing and marketing a broad-range of intelligent data management solutions which complement Varian, Inc.'s rapid drugs-of-abuse testing (DAT) products. These SMARTdata solutions enhance Varian, Inc.'s existing SMARTesting(TM) line of products by offering an automated means for gathering, analyzing, managing, and sharing outcomes. The company expects results to include more accountability, improved cost-savings, and streamlined processes for customers in both the criminal justice and workplace environments.
While all Varian, Inc.'s DAT products can be scanned, analyzed, reported and shared using the integrated data management software, OnSite(R) CupKit(TM) is the first of the DAT product line which streamlines the process further by automatically recognizing drug test results.
In addition to offering Sageful's enterprise data management solutions, Varian, Inc. is marketing a new suite of exclusive desktop solutions. These SMARTdata solutions address a wide spectrum of customer's needs: from a streamlined data recording product, TesTrak(TM), to a comprehensive information management solution, SMARTrak+(TM), that helps manage donors, results, schedules and chain-of-custody. Furthermore, all of these new solutions are available for a single workstation or an entire enterprise and all are fully upgradeable so customers can start with one system and seamlessly upgrade as their needs evolve.
For more than a decade, ANSYS Technologies and then Varian, Inc. (which acquired ANSYS in early 2002) were the exclusive manufacturer for Roche Diagnostics Corporation's drugs-of-abuse testing (DAT) business. In February 2003, Varian, Inc. purchased Roche's DAT business bringing the manufacturing, sales and marketing under one company. Since 1989, the OnoSite and OnTrak names have pioneered the industry with its convenient, cost-conscious drug screens delivering rapid, reliable results where and when needed the most. The advanced, patented manufacturing process uses latex technology to deliver results within five minutes surpassing the industry standard. These drug screens -- urine or saliva -- can be used for pre-employment screening, reasonable cause or incident-driven assessment, routine workplace testing, or court-mandated compliance.
Most read news
Organizations
Other news from the department business & finance
These products might interest you
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
HeartBeat.bio raises € 4.5 million in Pre-Series A financing - New funds to drive development of organoid screening platform for cardiac drug discovery
New computer vision system designed to analyse cells in microscopy videos
Musical sensor shows bad medicine plays false note - Inspired by a musical instrument, the simple sensor can be constructed from common materials and used to detect adulterated or counterfeit drugs
PerkinElmer and University of Copenhagen Announce Licensing Agreement for New Maternal Health Marker ADAM12
How can we fight blood cancer more effectively? - Several hundred different treatment combinations to be tested simultaneously outside the body
LGC announces plans to expand forensic services with new facilities to be created in Runcorn, Cheshire
Synthetic Production of Potential Pharmaceuticals Dramatically Simplified by Scripps Research Team - Findings Could Expand Interest in Natural Products by Making Production More Cost-Effective
Light-induced shape shifting of MXenes - Femtosecond light creates switchable nano-waves in MXenes and moves the materials’ atoms at a record-breaking speed
Brooks Instrument Joins Major Biotechnology Consortium Focused on Regenerative Drug Manufacturing - Brooks Instrument will contribute insights and precision fluid control technology to the Advanced Regenerative Manufacturing Institute’s BioFabUSA program
Promising discovery for a non-invasive early detection of Alzheimer's disease
Innovations through hair-thin optical fibres - Study shows what miniaturised optical filters make possible